1. Home
  2. PARR vs OGN Comparison

PARR vs OGN Comparison

Compare PARR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Par Pacific Holdings Inc.

PARR

Par Pacific Holdings Inc.

HOLD

Current Price

$53.93

Market Cap

1.9B

Sector

Energy

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.41

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARR
OGN
Founded
1984
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
PARR
OGN
Price
$53.93
$6.41
Analyst Decision
Hold
Hold
Analyst Count
5
4
Target Price
$48.80
$11.75
AVG Volume (30 Days)
1.3M
3.7M
Earning Date
05-26-2026
05-14-2026
Dividend Yield
N/A
1.26%
EPS Growth
1313.56
N/A
EPS
7.16
0.72
Revenue
$2,443,066,000.00
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$4.98
$1.67
P/E Ratio
$7.42
$8.79
Revenue Growth
30.99
N/A
52 Week Low
$12.04
$6.18
52 Week High
$54.23
$15.88

Technical Indicators

Market Signals
Indicator
PARR
OGN
Relative Strength Index (RSI) 73.24 32.12
Support Level $33.67 $6.18
Resistance Level N/A $7.87
Average True Range (ATR) 2.44 0.26
MACD 0.81 -0.07
Stochastic Oscillator 98.58 7.15

Price Performance

Historical Comparison
PARR
OGN

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: